Dr. David J. Peterson, D.O. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tamc, HI 96859 Phone: 808-433-5198 Fax: 808-433-6127 |
News Archive
A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results in patients in a phase I/II clinical trial.
BrainStorm Cell Therapeutics Inc. a leading developer of adult stem cell technologies and therapeutics, today announced that the Israeli Ministry of Health (MOH) has granted clearance for a Phase I/II clinical trial using the company's autologous NurOwn stem cell therapy in patients with amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's Disease.
The GOP is showing signs it intends to go even farther to use the health law to win or retain Senate seats this election cycle.
Meaningful social interactions are critical to an individual's well-being, and such interactions rely on people's behaviors towards one another.
"North Korea announced on Wednesday that it would suspend its nuclear weapons tests and uranium enrichment and allow international inspectors to monitor activities at its main nuclear complex," a move "signaling that North Korea's new leader, Kim Jong-un, is at least willing to consider a return to negotiations and to engage with the United States, which pledged in exchange to ship tons of food aid to the isolated, impoverished nation," the New York Times reports.
› Verified 2 days ago